Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Q3 2022 Program Management Update

31 Oct 2022 07:00

RNS Number : 5708E
R&Q Insurance Holdings Ltd
31 October 2022
 

 

R&Q Insurance Holdings Ltd

 

Q3 2022 Program Management Update

 

GWP grows by over 80% to $1.3 billion for the nine months ending 30 September 2022

 

31 October 2022

 

R&Q Insurance Holdings Ltd, (AIM-RQIH) ("R&Q"), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, announces a performance update for its Program Management business for the nine months ending 30 September 2022.

 

Highlights

 

· Gross Written Premium ('GWP') of $1.3 billion (9m 2021: $714 million), an 83% increase

 

· Program Fee Income of $60 million (9m 2021: $30 million), a 100% increase1

 

William Spiegel, Executive Group Chairman, commented:

 

"Our Program Management business exhibited strong year-over-year growth as we continued to expand the depth and breadth of our MGA partnerships through the first nine months of 2022. Our team continues to find new and unique ways to meet the needs of our MGAs and reinsurance partners, as demonstrated in our recently announced multi-year transaction with Inperio. Additionally, I am pleased to report that our growth is broad-based with all three of our platforms (US Admitted, US Non-Admitted, and Europe) growing GWP and Fee Income. Looking forward, our pipeline of new MGA opportunities remains strong."

 

Notes:

1. Program Fee Income is on a written basis and excludes our share of earnings from minority stakes in MGAs.

 

Ends

 

Enquiries to:

 

R&Q Insurance Holdings Ltd

William Spiegel

Tel: 0207 780 5850

Tom Solomon

Tel: 0207 780 5850

Alan Quilter Tel: 020 7780 5960

 

Numis Securities Limited (Nominated Advisor and Joint Broker)

Giles Rolls 

Tel: 020 7260 1000

Charles Farquhar 

 

Barclays Bank PLC (Joint Broker)

Andrew Tusa

Anusuya Nayar Gupta

Tel: 020 7260 1000

 

 

Tel: 020 7632 2322

Tel: 020 7632 2322

FTI Consulting

Tom Blackwell

 

Tel: 020 3727 1051

 

 

 

Notes to Editors:

 

About R&Q 

 

R&Q is a global non-life specialty insurance company. We operate two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in their respective markets.

 

Our approach is to deploy our origination and underwriting capabilities, alongside our licensed and rated carriers in the US, EU and the UK, to generate attractive fee returns in Program Management and Legacy Insurance.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBKKBNDBDDFKN
Date   Source Headline
20th Sep 20177:00 amRNSR&Q completes novation
6th Sep 20177:00 amRNSNotice of General Meeting and Return of Capital
4th Sep 20177:00 amRNSInterim Results
3rd Aug 20179:40 amRNSIssue of equity
30th Jun 20174:20 pmRNSR&Q writes facultative reinsurance certificate
30th Jun 20173:00 pmRNSCompletion of the acquisition
30th Jun 20172:13 pmRNSNotification of Major Interest in Shares
30th Jun 201711:09 amRNSNotification of Major Interest in Shares
30th Jun 201710:47 amRNSNotification of Major Interest in Shares
30th Jun 201710:45 amRNSNotification of Major Interest in Shares
30th Jun 201710:38 amRNSDisposal
30th Jun 201710:06 amRNSDirector/PDMR shareholding
29th Jun 201711:21 amRNSPDMR Share Dealings
23rd Jun 20177:00 amRNSR&Q to sell Lloyd's Managing Agency
20th Jun 20177:00 amRNSR&Q completes Loss Portfolio Transfer
19th Jun 20177:00 amRNSR&Q completes Loss Portfolio Transfer
1st Jun 20174:03 pmRNSResult of Annual General Meeting
12th May 20177:00 amRNSAccredited Completes Transaction
9th May 20177:00 amRNSNotice of AGM and Proposed Return of Capital
24th Apr 201712:42 pmRNSDistribution of Annual Report & Accounts
20th Apr 20177:00 amRNSFull year results
3rd Apr 20175:03 pmRNSNotice of Results
29th Mar 20175:35 pmRNSNotification of Major Interest in Shares
29th Mar 201710:12 amRNSNotification of Interest in Shares
28th Mar 201711:42 amRNSNotification of Major Interest in Shares
28th Mar 201710:16 amRNSNotification of Major Interest in Shares
27th Mar 20174:03 pmRNSResult of General Meeting
22nd Mar 20177:00 amRNSAcquisition
21st Mar 20178:06 amRNSAcquisition
7th Mar 20171:04 pmRNSDirector/PDMR Shareholding
6th Mar 20177:00 amRNSBroker Option update
2nd Mar 20173:05 pmRNSPosting of Circular
28th Feb 20177:00 amRNSPlacing to raise £16.9 million
20th Jan 20177:00 amRNSIssue of Subordinated Notes
19th Jan 20177:00 amRNSAccredited Agreement
6th Jan 20177:00 amRNSNovation
5th Jan 20171:25 pmRNSAcquisition
30th Dec 201612:10 pmRNSAcquisition
28th Dec 20167:00 amRNSNovation
23rd Dec 20163:38 pmRNSAcquisition
13th Dec 20167:00 amRNSR&Q writes deductible reimbursement policy
24th Nov 20167:00 amRNSNovation
17th Nov 20163:33 pmRNSDirector/PDMR Shareholding
7th Nov 20167:00 amRNSRun-off Arrangement
12th Oct 20164:25 pmRNSAllotment of Shares
6th Oct 20163:25 pmRNSResult of General Meeting
30th Sep 20167:00 amRNSPortfolio Transfer
28th Sep 20163:00 pmRNSDirector/PDMR Shareholding
28th Sep 20167:00 amRNSPortfolio Transfer
23rd Sep 20167:01 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.